+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North American Artificial Tears Market 2019-2025

  • PDF Icon


  • January 2020
  • Region: North America
  • Orion Market Research Private Limited
  • ID: 4901042
The North American artificial tears market is estimated to grow modestly at a CAGR of around 3.9% during the forecast period. North America has a considerable market share in the artificial tears market due to its ability of the region to develop advanced technology through integrated research and innovation in the production of solutions for dry eye syndrome. Moreover, increasing demand for contact lenses is also primarily boosting the market growth in the region. An increase in consumer awareness about the product and cases of dry eye syndrome in these regions supports the market growth.

The North American market for artificial tears is analyzed based on countries such as the US and Canada. The growth in the North American region is further attributed to the rising demand for contact lens among different age group people leads the adoption of artificial tears and enabling the market to grow further in the region. For instance, according to the Centers for Disease Control & Prevention (CDC), in 2016, an estimated 45 million Americans used contact lenses, of which 14.5% of adolescents were 17 years or younger wore contact lenses. In 2016, an estimated 3.6 million (14.5%) adolescents and 7.5 million (24.4%) young adults aged 18-24 wore contact lenses.

The companies which are contributing to the growth of the North American artificial tears market include Johnson & Johnson Services Inc., Akorn, Inc., Alcon, Inc., Bausch & Lomb Inc., and CooperVision, Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market. For instance, in May 2018, Teva Canada Ltd. launched Teva-Cyclosporine ophthalmic emulsion, 0.05% which is an eye drop used in the treatment of dry eye can be used twice-day. In 2017, the company launched generic Pataday1 (olopatadine hydrochloride ophthalmic solution) 0.2%, in the US.

Research Methodology

The market study of the North American artificial tears market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for drug manufacturers, healthcare providers, government organizations for overall market analysis, and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. North American Artificial Tears Market Research and Analysis by Type
2. North American Artificial Tears Market Research and Analysis by Delivery Method
3. North American Artificial Tears Market Research and Analysis by Application

The Report Covers:
  • Comprehensive research methodology of the North American artificial tears market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the North American artificial tears market.
  • Insights about market determinants which are stimulating the North American artificial tears market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. North American Artificial Tears Market by Type
5.1.1. Cellulose Derived Tears
5.1.2. Glycerin Derived Tears
5.1.3. Oil-Based Emulsion Tears
5.2. North American Artificial Tears Market by Delivery Method
5.2.1. Artificial Eye Drops
5.2.2. Ointments
5.3. North American Artificial Tears Market by Application
5.3.1. Dry Eyes Treatment
5.3.2. Contact Lens Moisture
5.3.3. Others
6. Regional Analysis
6.1. United States
6.2. Canada
7. Company Profiles
7.1. Akorn, Inc.
7.2. Alcon, Inc.
7.3. Altaire Pharmaceuticals, Inc.
7.4. Bausch & Lomb Inc.
7.5. CooperVision, Inc.
7.6. Johnson & Johnson Services Inc.
7.7. OCuSOFT, Inc.
7.8. Similasan Corp.
7.9. STAAR Surgical Co.
7.10. Teva Pharmaceuticals Industries, Ltd.
7.11. Valent Pharmaceuticals International, Inc.
7.12. Ziemer Ophthalmic Systems AG

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Akorn, Inc.
  • Alcon, Inc.
  • Altaire Pharmaceuticals, Inc.
  • Bausch & Lomb Inc.
  • CooperVision, Inc.
  • Johnson & Johnson Services Inc.
  • OCuSOFT, Inc.
  • Similasan Corp.
  • STAAR Surgical Co.
  • Teva Pharmaceuticals Industries, Ltd.
  • Valent Pharmaceuticals International, Inc.
  • Ziemer Ophthalmic Systems AG